Clinical Evaluation of Zirconia Reinforced Versus Conventional Viscous Glass Ionomer in Posterior Restorations of Geriatric Patients: Randomized Controlled Trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 1
- 主要终点
- Clinical performance
研究概览
简要总结
This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities
详细描述
This study will be conducted to determine the clinical performance of the Zirconia reinforced glass ionomer restorations ( Zirconomer improved) under stress bearing posterior area (class I or claa II cavities) in geriatric population in comparison to Conventional viscous glass ionomer restorations (Ketac molar quick Aplicap) using the modified United States Public Health Service (USPHS) criteria
P: Geriatric Patients with posterior Caries lesions I: Zirconia reinforced GI (Zirconomer Improved) C: Conventional viscous GI, (Ketac Molar quick Aplicap) O: The Clinical performance of the Glass Ionomer restorations Using USPHS Criteria
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age range 60-80 years
- •Geriatric patients with Class I or II Posterior carious lesions.
- •Males or Females.
- •Pulp asymptomatic vital carious posterior teeth.
- •Co-operative patients approving to participate in the trial.
排除标准
- •Age range less than 60 years.
- •Disabilities.
- •Deep extensive carious cavities that may lead to fracture of the tooth or pulpal affection.
- •Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
- •Heavy smoking.
- •Lack of compliance.
研究组 & 干预措施
zirconomer improved
zirconia reinforced glass ionomer restoration
干预措施: Zirconomer Improved (Drug)
ketac molar quick aplicap
conventional viscous glass ionomer restoration
干预措施: Ketac Molar quick Aplicap (Drug)
结局指标
主要结局
Clinical performance
时间窗: 1 year
clinical performance of the Glass Ionomer restorations using modified USPHS criteria
次要结局
未报告次要终点
研究者
Doaa Mohammed Mohammed Abdou
Assistant lecturer
Cairo University